Dr. Mike Hutton Joins TRIMTECH Therapeutics: Advancing Neurodegenerative Disease Research
Автор: All Around View
Загружено: 2025-11-15
Просмотров: 1
Описание:
TRIMTECH Therapeutics welcomes Dr. Mike Hutton to their Scientific Advisory Board, bringing over 30 years of expertise in neurodegenerative disease research and drug development. Dr. Hutton will guide the company's targeted protein degradation pipeline, focusing on Alzheimer's and Parkinson's disease targets.
With his impressive background, including roles at Eli Lilly, MSD, and Mayo Clinic, Dr. Hutton has made significant contributions to understanding fronto-temporal dementia and tau-related research. His expertise will be invaluable in developing novel small molecule therapeutics for these challenging neurological disorders.
This appointment highlights TRIMTECH's commitment to assembling a top-tier team to address the critical need for accessible and effective treatments for neurodegenerative diseases.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
